SK Life Science, Inc., the U.S. subsidiary of SK Biopharmaceuticals, is an innovative global pharmaceutical company focused on the research, development and treatment of central nervous system (CNS) disorders. The company has a pipeline of eight compounds in development for CNS disorders including epilepsy.
We recognize the nearly 65 million people worldwide with epilepsy.
We’re inspired by you and dedicated to improving awareness and care.
“We are committed to listening to the unique needs of the epilepsy community and providing support for innovative programs that can help improve lives. We know progress requires a consistent, collective effort, and it is a privilege to recognize this dynamic community every day.”
As long as there are unmet needs in the epilepsy and the CNS community, we keep working. We explore the complex mysteries of the brain to find answers for patients, caregivers, and healthcare professionals, because you’re worth it.
Check out these resources we developed for the epilepsy community:
We are proud of our sponsors and appreciate their continued support